Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2024-08-12 00:00:00 ET · period of report 2024-08-12 · accession 0001493152-24-031416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | 2024-08-12 | AIM | Rodino Peter W III | COO, Sec, Gen. Counsel | A - Grant | $0.27 | +188.7K | 401.3K | +89% | +$50.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | A | A | 188,679 | $0.27 | 401,262 | D | — | — |